PRESS RELEASE: A Novel Biomarker For DeltaRex-G CCNG-1 Inhibitor Therapy

AI analysis showed enhanced CCNG1 oncogene expression in all tumors of patients with osteosarcoma, chondrosarcoma, leiomyosarcoma and other soft tissue sarcomas